Divi's Laboratories Limited (DIVISLAB.NS)

INR 5839.8

(-0.17%)

Market Cap (In INR)

1550.28 Billion

Revenue (In INR)

78.45 Billion

Net Income (In INR)

16 Billion

Avg. Volume

569.48 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3350.0-6285.45
PE
-
EPS
-
Beta Value
0.349
ISIN
INE361B01024
CUSIP
Y2076F112
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Employee Count
-
Website
https://www.divislabs.com
Ipo Date
2003-03-12
Details
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.